mitoxantrone has been researched along with Carcinoma, Intraepithelial in 5 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| " All patients were given 4-6 doses of intravesical novantrone at the same dose level at weekly dosing interval." | 6.67 | Phase I-II evaluation of intravesical novantrone (mitoxantrone) in superficial bladder cancer. ( Albert, D; Clayton, M; Lamb, D; Lee, M; Sarosdy, M; Sharifi, R; Siami, P; Strub, M, 1991) |
| " All patients were given 4-6 doses of intravesical novantrone at the same dose level at weekly dosing interval." | 2.67 | Phase I-II evaluation of intravesical novantrone (mitoxantrone) in superficial bladder cancer. ( Albert, D; Clayton, M; Lamb, D; Lee, M; Sarosdy, M; Sharifi, R; Siami, P; Strub, M, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Manyak, MJ | 1 |
| Namasivayam, S | 1 |
| Whelan, P | 1 |
| Vinnicombe, SJ | 1 |
| MacVicar, AD | 1 |
| Guy, RL | 1 |
| Sloane, JP | 1 |
| Powles, TJ | 1 |
| Knee, G | 1 |
| Husband, JE | 1 |
| Obermann, E | 1 |
| Meidenbauer, N | 1 |
| Zeltner, R | 1 |
| Andreesen, R | 1 |
| Reichle, A | 1 |
| Sharifi, R | 1 |
| Lee, M | 1 |
| Clayton, M | 1 |
| Lamb, D | 1 |
| Siami, P | 1 |
| Strub, M | 1 |
| Albert, D | 1 |
| Sarosdy, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pilot Study: Monitoring of Breast Cancers Treated by Neoadjuvant Therapy Via Diffusion-weighted Magnetic Resonance Imaging[NCT02798484] | 61 participants (Actual) | Interventional | 2016-06-21 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for mitoxantrone and Carcinoma, Intraepithelial
| Article | Year |
|---|---|
Intravesical mitozantrone in recurrent superficial bladder cancer: a phase II study.
Topics: Administration, Intravesical; Aged; Aged, 80 and over; Carcinoma in Situ; Carcinoma, Transitional Ce | 1995 |
Primary breast cancer: mammographic changes after neoadjuvant chemotherapy, with pathologic correlation.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Car | 1996 |
Phase I-II evaluation of intravesical novantrone (mitoxantrone) in superficial bladder cancer.
Topics: Aged; Carcinoma in Situ; Carcinoma, Transitional Cell; Drug Evaluation; Female; Humans; Male; Middle | 1991 |
2 other studies available for mitoxantrone and Carcinoma, Intraepithelial
| Article | Year |
|---|---|
Bladder carcinoma--the good, the bad and the ugly.
Topics: Administration, Intravesical; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Prot | 1996 |
Multifocal reversible epithelial dysplasia mimicking carcinoma in situ after conditioning therapy with busulfan and cyclophosphamide.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Carcinoma in Situ; Cyclophosphamide | 1999 |